Jafron Biomedical Co.,Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Jianfan Biotechnology Group Co., Ltd. was founded in 1989, specializing in the research and development, production, and sales of biomaterials and high-tech medical devices. It is an A-share ChiNext listed company with blood purification products as its main business (stock code: 300529). At present, the company ranks among the top 500 listed companies in China by market value, and is firmly among the top medical device listed companies in China. It has been awarded the "Golden Bull Most Valuable Investment Award" in 2017, 2018, and 2019, as well as the "Top 50 Listed Companies on the Growth Enterprise Market" in 2018, 2019, and 2020. In 2019, it was awarded the "Best Shareholder Reporting Listed Company" and the "Competitive Enterprise" on the Growth Enterprise Market in the Financial Times List. It has been listed as one of the top 100 health private enterprises in Hurun China in 2020, with a corporate tax payment of over 300 million yuan. Jianfan has won the "Second Prize of National Science and Technology Progress Award", "Key High tech Enterprise of National Torch Plan", and "Golden Bridge Award of China Technology Market Association". It is one of the first batch of enterprises in China and the second enterprise in Guangdong Province to pass the GMP inspection of medical devices. It has been selected as a national industrial revitalization and technological transformation project, a national major scientific and technological achievement transformation project, a core technology research project for strategic emerging industries in Guangdong Province, and a national 12th Five Year Science and Technology Support Plan project. In 2019, the company was selected as a "benchmark enterprise in the pharmaceutical industry for the 70th anniversary of the founding of the People's Republic of China". The company's products have passed CE certification and ISO international quality management system certification, and have been rated as a Class A medical device production enterprise in Guangdong Province for ten consecutive years. It has undertaken two "National Key New Product Projects" and three "National Torch Plan Projects", and has been approved to establish the Guangdong Blood Purification Engineering Technology Research and Development Center, Provincial Enterprise Technology Center, Doctoral Research Workstation, Postdoctoral Research Workstation, and Academician Workstation. The company has strong research and development, production capabilities, and a sales network throughout the country. Its main products include "DNA immunosorbent column", "plasma bilirubin adsorber", and "resin blood perfusion device", with a high market share. In 2019, Jianfan Biological Blood Purification Machine and Blood Perfusion Machine were selected as the fifth batch of excellent domestic medical equipment products. The newly established blood purification research and production base (Jianfan Science and Technology Park) invested by the company was successfully completed and put into operation in 2015. In the past two years, the company has established new markets, research centers, and production bases in Beijing Tianjin, Guangzhou Shenzhen, Hubei and other places, along with the existing production base of Zhuhai Jianfan Science and Technology Park, to form an industrial layout in South China, Central China, and North China. In 2025, Jianfan will create a unique "product service finance+internet" integrated blood purification full value chain, achieving collectivization, branding, and diversified development, laying a solid foundation for its corporate vision of becoming a "world-class high-tech medical technology enterprise group". We believe that high-tech products+high-quality talents+high-quality services=success in the near future. |
| Headquarter | Zhuhai |
| Establish Date | 12/19/1989 |
| Listed Code | 300529.SZ |
| Listed Date | 8/2/2016 |
| Chairman | Dong Fan. |
| CEO | Dong Fan. |
| Website | www.jafron.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
